Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 18.95% is 225% above its 5-year average of 5.83%, near the high end of its 5-year range (0.00%–18.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 45.14% above its 12-month average of 13.06%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 18.95%.
DEBT TO ASSETS RATIO
18.95%
DEBT TO ASSETS RATIO AVG TTM
13.06%
DEBT TO ASSETS RATIO AVG 3Y
8.71%
DEBT TO ASSETS RATIO AVG 5Y
5.83%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+45.14%
CURRENT VS 3Y AVG
+117.63%
CURRENT VS 5Y AVG
+225.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 779 covered companies
CURRENT VS SECTOR MEDIAN
+20958.06%
vs the sector median at left
NextCure, Inc.
Market Cap
$18.95M
Debt to Assets Ratio
18.95%
TTM Avg
13.06%
3Y Avg
8.71%
5Y Avg
5.83%
Market Cap
$18.97M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.65M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.55M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.77M
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $18.95M | 18.95% | 13.06% | 8.71% | 5.83% |
| P3 Health Partners Inc. (PIII)vs › | $18.97M | 0.20% | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 0.00% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.55M | 0.00% | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.77M | 0.08% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $17.65M | 0.26% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.30M | 0.00% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 0.00% | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $16.98M | 0.42% | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | 0.07% | N/A | N/A | N/A |
Debt/Assets
19.0%
Debt/Equity
0.35
Current Ratio
3.47
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 18.95% |
| 2026-03-31 | 12.97% |
| 2025-12-31 | 10.27% |
| 2025-09-30 | 11.98% |
| 2025-06-30 | 11.12% |
| 2025-03-31 | 8.70% |
| 2024-12-31 | 7.36% |
| 2024-09-30 | 6.28% |
| 2024-06-30 | 6.00% |
| 2024-03-31 | 5.75% |
| 2023-12-31 | 5.16% |
| 2023-09-30 | 4.57% |
| 2023-06-30 | 4.10% |
| 2023-03-31 | 4.31% |
| 2022-12-31 | 3.87% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.96% |
| 2021-03-31 | 1.05% |
| 2020-12-31 | 1.13% |
| 2020-09-30 | 1.23% |
| 2020-06-30 | 1.29% |
| 2020-03-31 | 1.38% |
| 2019-12-31 | 1.44% |
| 2019-09-30 | 2.44% |
| 2019-06-30 | 2.35% |
| 2019-03-31 | 3.44% |
| 2018-12-31 | 0.40% |
